Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
3.950
-0.010 (-0.25%)
Jun 25, 2026, 1:51 PM EDT - Market open
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $275.75 million as of June 25, 2026. Its market cap has decreased by -53.91% in one year.
Market Cap
275.75M
Enterprise Value
-264.89M
1-Year Change
-53.91%
Ranking
Category
Stock Price
$3.95
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $275.75M, an increase of 29.85%. That is a compound annual growth rate of 3.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 275.75M | -43.85% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 287.41M |
| Conexeu Sciences | 286.05M |
| InflaRx | 284.28M |
| Cartesian Therapeutics | 283.24M |
| Zentalis Pharmaceuticals | 282.61M |
| Adagene | 280.81M |
| Niagen Bioscience | 275.35M |
| Invivyd | 275.10M |